SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-017969
Filing Date
2011-02-24
Accepted
2011-02-24 17:22:50
Documents
3
Period of Report
2011-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g26276e8vk.htm 8-K 12980
2 EX-99.1 g26276exv99w1.htm EX-99.1 15498
3 GRAPHIC g26276g2627600.gif GRAPHIC 4090
  Complete submission text file 0000950123-11-017969.txt   35834
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 11637512
SIC: 2836 Biological Products, (No Diagnostic Substances)